Xanit and the AECC boarded on a day the prevention, diagnosis and treatment of cancer.
this event, which took place last Friday February 3 in the hospital, there was on the occasion of the world day of cancer.
Read MoreAlmirall celebrates 10 years in Mexico.
Barcelona, February of 2012- Almirall, based on innovation and committed to health, global company celebrates 10 years in Mexico.
Almirall Mexico has launched in the past three years, nine products for the treatment of diseases such as irritable bowel syndrome, gastroesophageal reflux and dyspepsia, among others, as well as a dermatological line for the treatment of skin diseases.
Recently, Almirall Mexico has received the distinctive practices transparent company by its ethical commitment.
In the words of Israel GarcÃa, Director General at Mexico, “ the success of our releases has consolidated our presence in Mexico after 10 years of continuous growth. Our goal is to continue to offer therapeutic solutions with high added value to Mexican society ”.
Israel Garcia, General Manager of Almirall Mexico.
In order to celebrate this anniversary, pharmaceutical company held a commemorative event in the Museum of Mexico economy, Mexico City, attended, as well as Almirall Mexico team and other members of the company, industry and health sector personalities.
Commitment to innovation and internationalization have allowed the expansion of Almirall around the world. Today, Almirall has 12 members in Europe and Latin America, and their own research drugs are present in 70 countries on five continents.
Almirall
Almirall is an international pharmaceutical company based on innovation and committed to health. With headquarters in Barcelona (Spain), Almirall researches, develops, produces and sells drugs own r & d and licensing with the aim of improving the health and well-being of people.
The therapeutic areas in which concentrates its resources in research are related to the treatment of asthma, COPD (chronic obstructive pulmonary disease), gastrointestinal disorders, psoriasis and other skin complaints forms.
Almirall drugs are now present in more than 70 countries. It has direct presence in Europe and Latin America through subsidiaries 12.
Read More
Transfusion Center and Department Arnaldus de appreciate the solidarity of Paterna.
-the day of the donation of Paterna exceeded all forecasts and nearly doubled the influx of people flocked to donate blood
Valencia, February 2012. Saturday, January 28, a mobile unit of the Centre for transfusion moved to Paterna Colegio Miguel de Cervantes to celebrate the day of blood donation. It was an extraordinary donation, as every month come in addition to the usual points.
Trasfusión Center celebrates this kind of action in a timely manner in different localities to encourage and raise in blood donation. In the words of its director Dr. Roberto Roig, “ is getting our goal between the population. want to raise awareness about the need and importance of blood for the operation of hospitals and ultimately to each of us. This weekend Paterna has given a great example ”.
From the year 2009 was not celebrated this campaign in Paterna and had forecast that at least 150 neighbors come to collaborate with your donation. But reality surpassed all forecasts since that was attended by 239 neighbors, whose donation was 225 effective units of blood, with 16 people who came for the first time to donate.
Comunitat transfusion Center and the Department of health Valencia – Arnau de Vilanova appreciates the interest shown by the campaign, which was visited by the Councillor for health, peace Rodriguez to City Hall. You were also with the collaboration of Caixa Rural de Torrent, which presented donors with a blanket.
Last year were 974 effective units of blood in the town of Paterna. During the 2011 donors attended the points in common, such as the Capri theatre and the Centre of health, as well as companies, institutes and other agencies or local associations. It is worth mentioning the IES Henri Matisse, Parque Tecnológico AIDO, meat Serrano, Mercadona, Valterna, the trade fair, the French Lyceum, Mariner, Asivalco and Biomet Spain Orthopaedics SL.
Donation of the past year 2011 Paterna index approached 20 per thousand inhabitants and its region L ’ Horta West is situated on a 21 per thousand inhabitants.
Next Paterna blood drive campaign will be held on February 24, Friday, at the health centre (plaza Joan Clot s/n), and on the same day at the Capri Theatre (w/ Ernesto Ferrando No. 7). The two will start at 17: 00 and finish at 20: 30 hours. “ Hope that this ordinary campaign encourage many neighbors and help with gestures as the lived experience last Saturday to raise awareness that blood is a good precious and irreplaceable, and that any of us can you need at any time ”.
Read More
Peritoneal dialysis is effective in the treatment of heart failure.
Oviedo hosts the VIII national meeting of Diálisis Peritoneal.
-heart failure is the third leading cause of death of cardiovascular origin and the first hospital admission in patients over 65 years of
-peritoneal dialysis improves the quality of life, survival, reduces hospital admissions and costs of treatment in patients with refractory heart failure
Madrid, February 2012.- cardiac insufficiency La (IC) in Spain reaches a prevalence of 6% in the population over 40 years, amounting to 16% in people over the age of 75. Addition, it is the leading cause of hospital admission en mayores de 65 años and, in general, causes more than 80,000 annual hospitalizations. The IC is the third cause of cardiovascular death in Spain. All these factors make the IC an important disease and a public health problem.
Heart failure is a chronic disease usually treated with drugs, but there are patients who do not respond to treatment. Peritoneal dialysis has been very effective for them. In fact, on the application of this technique in failure chronic renal will be discussed on Friday at the VIII national meeting of Peritoneal Dialysis in Oviedo.
Obvious advantages of peritoneal dialysis
(1) Recent studies have shown that peritoneal dialysis improves the quality of life, survival, decreases hospital admissions and reduces the costs of treatment in patients with heart failure.
Using DP costs are reduced, since that analysis of coste-utilidad reflects that DP mode has a cost of 23.305 euros a year, adjusted for quality of life, while traditional conservative treatment involves a cost of 81.503 euros a year, according to the studies carried out by the team of Nephrology of the Hospital Universitario Central de Asturias.
According to DRA. Carmen RodrÃguez, studies show that using DP in this type of patient, front that they used only conventional treatments, patients show a significant improvement in their symptoms, reduces the rate of hospital admissions (from 62 to 11 days of income per year at risk) and mortality is reduced (82% a year survival and 56 per cent for the two year)(os, versus conservative treatment which reflects a median survival of 25% annually). Thus, peritoneal dialysis is a perfect complement to treatment as usual, helping the Elimination of liquids in patients who do not respond to the diuretic therapy.
Home peritoneal dialysis
Peritoneal dialysis removes excess fluid of patients with refractory heart failure. It is a very simple method that the patient performs at home. The only patient attends hospital for review every one or two months. This helps the patient continue with his usual life and gives you greater freedom and privacy in their treatments.
referencia:
(1) j. e. Sánchez, C. Rodriguez, i. González, a. Fernández-Viña, M. Núñez, and B. Peláez “ analysis of the advantages of peritoneal dialysis in the treatment of chronic refractory heart failure ” Nephrology 2010; 30 (5): 487-9
j. D. MontejoM. a. bass, G. Weight, r. Selgas “ role of peritoneal dialysis in the treatment of refractory heart failure ” Nephrology 2010; 30: 21-7
Read More
Alofibras, control weight and health naturally.
-Coll Farma launches a nutritional supplement based on fiber soluble in dust, ideal for the extra kilos
-Helps reduce weight and regulates intestinal transit painlessly and naturally
Spain, February 2012.- nowadays, obesity is a public health problem. According to the who declares, it’s the epidemic of the 21st century, because that causes significant morbidity who suffers, increased risk of mortality and a very high health cost. In the case of Spain, 14.5 per cent of the adult population suffers from obesity, overweight compared to 38.5%.
Despite the data, society is gradually taking consciousness of the importance of maintaining a healthy and balanced diet. Therefore, Coll Pharma laboratories launches Alofibras, dietary supplement powder soluble fibre.
It is a new product with Meticelulosa, its main component, which acts directly on the digestive tract, increasing the volume of the intestinal content and generating a feeling of satiety which causes a reduction in food intake. It also reduces the absorption of energy nutrients due to its ability to catch proteins, carbohydrates, and fats. It is for these reasons that are considered a good coayudante for weight loss.
In addition, Alofibras regulates intestinal transit in a natural way and includes all the benefits of products based on dietary fibre, without unwanted as gas or the cramping effects.
At the same time, it’s a natural and effective laxative that absorbs part of ingested fats and sugars and reduces the level of cholesterol.
is scientifically proven that a diet rich in fiber is beneficial for the body. Thus Alofibras helps prevent constipation, because it acts to regulate the intestinal transit, in addition to reducing the intake of calories, because it creates satiety.
la Fibroterapia and the importance of a diet rich in fiber
La Fibroterapia is an integrated treatment serving mainly the digestive system, decreasing the time of intestinal transit and thus, increasing the frequency of evacuation to accelerate the process.
In healthy eating is essential to include a content adapting fibre, because as well as prevent and relieve constipation, favoring the intestinal regulation, helps control weight and prevent obesity.
According to the WHO-FAO, depending on age and sex, recommends consumption of fiber of between 20 and 30 grams per day.
Alofibras with orange flavour, can be found in pharmacies, parapharmacies and herbalists in format of envelopes of 7.5 grams, contained in boxes of 20 envelopes.
About Coll Farma
Created in Barcelona, Coll-Farma has over 50 years of experience in the marketing of pharmaceutical products. Specialist in other lines of pharmacy, as medicinal teas, also has other products of long trajectory in the Spanish market.
Read More